Publications by authors named "Kuldip D Dave"

Claim this Profile
D
Design considerations for C9orf72 disease prevention trials.
Michael Benatar, Adam M Staffaroni, Joanne Wuu, Michael P McDermott, Melanie Quintana, Kuldip D Dave

Brain· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Amyotrophic Lateral Sclerosis Prevalence Projection in 2040: A Less Rare Disease.
Rosario Vasta, Stefano Callegaro, Antonio Canosa, Umberto Manera, Maurizio Grassano, Kuldip D Dave

Ann Clin Transl Neurol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Medicare expenditures in the first year of amyotrophic lateral sclerosis diagnosis.
Melissa Morley, Marisa Aurora, Kolton Gustafson, Chani S Seals, Ari Feuer, Kuldip D Dave

Am J Manag Care· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Contributions of neurologists to diagnostic timelines of ALS and thinkALS as an early referral instrument for clinicians.
Kuldip D Dave, Björn Oskarsson, Jill Yersak, Ramona Krauss, Terry Heiman-Patterson

Amyotroph Lateral Scler Frontotemporal Degener· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A roadmap to ALS prevention: strategies and priorities.
Michael Benatar, Stephen A Goutman, Kim A Staats, Eva L Feldman, Marc Weisskopf, Kuldip D Dave

J Neurol Neurosurg Psychiatry· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The GBA1 D409V mutation exacerbates synuclein pathology to differing extents in two alpha-synuclein models.
Nicole K Polinski, Terina N Martinez, Sylvie Ramboz, Michael Sasner, Mark Herberth, Kuldip D Dave

Dis Model Mech· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antemortem detection of Parkinson's disease pathology in peripheral biopsies using artificial intelligence.
Maxim Signaevsky, Bahram Marami, Marcel Prastawa, Nabil Tabish, Megan A Iida, Kuldip D Dave

Acta Neuropathol Commun· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Decreased glucocerebrosidase activity and substrate accumulation of glycosphingolipids in a novel GBA1 D409V knock-in mouse model.
Nicole K Polinski, Terina N Martinez, Alexander Gorodinsky, Ralph Gareus, Michael Sasner, Kuldip D Dave

PLoS One· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vivo distribution of α-synuclein in multiple tissues and biofluids in Parkinson disease.
Lana M Chahine, Thomas G Beach, Michael C Brumm, Charles H Adler, Christopher S Coffey, Kuldip D Dave

Neurology· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Proposed Roadmap for Parkinson's Disease Proof of Concept Clinical Trials Investigating Compounds Targeting Alpha-Synuclein.
Kalpana M Merchant, Jesse M Cedarbaum, Patrik Brundin, Kuldip D Dave, Jamie Eberling

J Parkinsons Dis· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Best Practices for Generating and Using Alpha-Synuclein Pre-Formed Fibrils to Model Parkinson's Disease in Rodents.
Nicole K Polinski, Laura A Volpicelli-Daley, Caryl E Sortwell, Kelvin C Luk, Nunilo Cremades, Kuldip D Dave

J Parkinsons Dis· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Basal and Evoked Neurotransmitter Levels in Parkin, DJ-1, PINK1 and LRRK2 Knockout Rat Striatum.
Rose B Creed, Liliana Menalled, Bradford Casey, Kuldip D Dave, Holden B Janssens

Neuroscience· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antibody-based methods for the measurement of α-synuclein concentration in human cerebrospinal fluid - method comparison and round robin study.
Brit Mollenhauer, Frederick DuBois Bowman, Daniel Drake, Jimmy Duong, Kaj Blennow, Kuldip D Dave

J Neurochem· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunohistochemical Method and Histopathology Judging for the Systemic Synuclein Sampling Study (S4).
Thomas G Beach, Geidy E Serrano, Thomas Kremer, Marta Canamero, Sebastian Dziadek, Kuldip D Dave

J Neuropathol Exp Neurol· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapeutic approaches to target alpha-synuclein pathology.
Patrik Brundin, Kuldip D Dave, Jeffrey H Kordower

Exp Neurol· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Systemic Synuclein Sampling Study: toward a biomarker for Parkinson's disease.
Naomi P Visanji, Brit Mollenhauer, Thomas G Beach, Charles H Adler, Christopher S Coffey, Kuldip D Dave

Biomark Med· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The hTH-GFP reporter rat model for the study of Parkinson's disease.
Lorraine Iacovitti, Xiaotao Wei, Jingli Cai, Eric W Kostuk, Ruihe Lin, Kuldip D Dave

PLoS One· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Loss of leucine-rich repeat kinase 2 (LRRK2) in rats leads to progressive abnormal phenotypes in peripheral organs.
Marco A S Baptista, Kuldip D Dave, Mark A Frasier, Todd B Sherer, Melanie Greeley

PLoS One· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phenotypic characterization of recessive gene knockout rat models of Parkinson's disease.
Kuldip D Dave, Shehan De Silva, Niketa P Sheth, Sylvie Ramboz, Melissa J Beck

Neurobiol Dis· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Î
α-synuclein imaging: a critical need for Parkinson's disease research.
Jamie L Eberling, Kuldip D Dave, Mark A Frasier

J Parkinsons Dis· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A strategy for the generation, characterization and distribution of animal models by The Michael J. Fox Foundation for Parkinson's Research.
Marco A S Baptista, Kuldip D Dave, Niketa P Sheth, Shehan N De Silva, Kirsten M Carlson

Dis Model Mech· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serotonergic and dopaminergic distinctions in the behavioral pharmacology of (±)-1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI) and lysergic acid diethylamide (LSD).
Emmanuelle A D Schindler, Kuldip D Dave, Elaine M Smolock, Vincent J Aloyo, John A Harvey

Pharmacol Biochem Behav· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intrahippocampal LSD accelerates learning and desensitizes the 5-HT(2A) receptor in the rabbit, Romano et al.
Anthony G Romano, Jennifer L Quinn, Luchuan Li, Kuldip D Dave, Emmanuelle A Schindler

Psychopharmacology (Berl)· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Behavioral response to emotional stress in rabbits: role of serotonin and serotonin2A receptors.
Vincent J Aloyo, Kuldip D Dave

Behav Pharmacol· November 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The time-course for up- and down-regulation of the cortical 5-hydroxytryptamine (5-HT)2A receptor density predicts 5-HT2A receptor-mediated behavior in the rabbit.
Kuldip D Dave, John A Harvey, Vincent J Aloyo

J Pharmacol Exp Ther· October 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis